Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 2

The DOI matches its Crossref record; the references it cites are not checked yet.

Acceptability and preferences regarding RSV immunisation during pregnancy: a cross-sectional study in diverse global settings

Favre, Guillaume, Pfund, Anouck, Gerbier, Eva, Anselem, Olivia, Balaya, Vincent, Ceccaldi, Pierre-François, Chalouhi, Gihad, Ducarme, Guillaume, Garabedian, Charles, Guerby, Paul, Mottet, Nicolas, Picone, Olivier, Poncelet, Christophe, Quibel, Thibaud, Sananes, Nicolas, Sentilhes, Loïc, Simon, Julien, Tran, Phuong Lien, Ville, Yves, Baud, David, Blume, Carolin, Capoccia Brugger, Romina, Farin, Alexandre, Fougère, Yves, Fruscalzo, Arrigo, Gallmann, Dalia, Haslinger, Christian, Huber, Daniela, Martinez de Tejada, Begoña, Radan, Anda-Petronela, Schäffer, Leonhard, Todesco Bernasconi, Monya, Vökt, Cora, Miranda, Jezid, Nieto-Calvache, Albaro José, Rivera-Torres, Luisa Fernanda, De Santis, Marco, Kratochwila, Chiara, Paladini, Dario, Tantari, Matteo, Ernst, Corinna, Mossong, Joël, Murray, Jane, Feuerschuette, Otto Henrique May, Luz, Adriana Gomes, Surita, Fernanda, Boucoiran, Isabelle, Goncé, Anna, Higgins, Mary, Démolis, Rachel, Alexandre, Kétia, Pomar, Léo·2026·Vaccine
DOI 10.1016/j.vaccine.2026.128783
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.vaccine.2026.128783

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists haven’t been fetched yet

Cited by 2

Research works printed but not linked: 34

  1. Li, 2022, Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis, Lancet, 399, 2047, 10.1016/S0140-6736(22)00478-0 · DOI · Paper page
  2. Hammitt, 2022, Nirsevimab for prevention of RSV in healthy late-preterm and term infants, N Engl J Med, 386, 837, 10.1056/NEJMoa2110275 · DOI · Paper page
  3. Muller, 2023, Nirsevimab for prevention of RSV in term and late-preterm infants, N Engl J Med, 388, 1533, 10.1056/NEJMc2214773 · DOI · Paper page
  4. Kampmann, 2023, Bivalent Prefusion F vaccine in pregnancy to prevent RSV illness in infants, N Engl J Med, 388, 1451, 10.1056/NEJMoa2216480 · DOI · Paper page
  5. Munro, 2025, 180-day efficacy of nirsevimab against hospitalisation for respiratory syncytial virus lower respiratory tract infections in infants (HARMONIE): a randomised, controlled, phase 3b trial, Lancet Child Adolesc Health, 9, 404, 10.1016/S2352-4642(25)00102-6 · doi:10.1016/s2352-4642(25)00102-6
  6. Simoes, 2025, Efficacy, safety, and immunogenicity of the MATISSE (maternal immunization study for safety and efficacy) maternal respiratory syncytial virus prefusion F protein vaccine trial, Obstet Gynecol, 145, 157, 10.1097/AOG.0000000000005816 · doi:10.1097/aog.0000000000005816
  7. Sumsuzzman, 2025, Real-world effectiveness of nirsevimab against respiratory syncytial virus disease in infants: a systematic review and meta-analysis, Lancet Child Adolesc Health, 9, 393, 10.1016/S2352-4642(25)00093-8 · DOI
  8. Shoukat, 2023, Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of respiratory syncytial virus disease among infants in Canada: a simulation study, Lancet Reg Health Am, 28
  9. Li X, Bilcke J, Vazquez Fernandez L, et al. Cost-effectiveness of respiratory syncytial virus disease prevention strategies: maternal vaccine versus seasonal or year-round monoclonal antibody program in Norwegian children. J Infect Dis 2022; 226(Suppl 1): S95–S101. · DOI
  10. Baral, 2021, Impact and cost-effectiveness of potential interventions against infant respiratory syncytial virus (RSV) in 131 low-income and middle-income countries using a static cohort model, BMJ Open, 11, 10.1136/bmjopen-2020-046563 · DOI
  11. Perez Marc, 2025, Lancet Infect Dis, 25, 1044, 10.1016/S1473-3099(25)00156-2 · DOI
  12. Hodgson, 2024, Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination, Lancet Reg Health Eur, 38
  13. Stuckelberger, 2021, SARS-CoV-2 vaccine willingness among pregnant and breastfeeding women during the first pandemic wave: a cross-sectional study in Switzerland, Viruses, 13, 10.3390/v13071199 · DOI
  14. Lefebvre, 2019, Acceptance of pregnant women’s vaccination against pertussis among French women and health professionals: PREVACOQ-1 and -2 studies, Med Mal Infect, 49, 593, 10.1016/j.medmal.2019.09.001 · DOI
  15. Maisonneuve, 2023, Determinants of vaccination and willingness to vaccinate against COVID-19 among pregnant and postpartum women during the third wave of the pandemic: a European multinational cross-sectional survey, Viruses, 15, 10.3390/v15051090 · DOI
  16. Betsch C, Schmid P, Heinemeier D, Korn L, Holtmann C, Bohm R. Beyond confidence: development of a measure assessing the 5C psychological antecedents of vaccination. PLoS One; 2018: e0208601. · DOI · Paper page
  17. Rosenstock, 1988, Social learning theory and the health belief model, Health Educ Q, 15, 175, 10.1177/109019818801500203 · DOI · Paper page
  18. Kuntz JL, Babu TM, Feldstein LR, et al. Knowledge about respiratory syncytial virus and acceptance of infant monoclonal antibody for RSV and RSV vaccination during pregnancy. Pediatr Infect Dis J 2025; 44(2S): S162–S6. · doi:10.1097/inf.0000000000004566
  19. Sallam, 2025, Attitude to RSV vaccination among a cohort of pregnant women in Jordan: a cross-sectional survey study, Health Sci Rep, 8, 10.1002/hsr2.70319 · DOI · Paper page
  20. McClymont, 2025, Acceptance and preference between respiratory syncytial virus vaccination during pregnancy and infant monoclonal antibody among pregnant and postpartum persons in Canada, Vaccine, 50, 10.1016/j.vaccine.2025.126818 · DOI · Paper page
  21. Ernst, 2024, Impact of nirsevimab prophylaxis on paediatric respiratory syncytial virus (RSV)-related hospitalisations during the initial 2023/24 season in Luxembourg, Euro Surveill, 29, 10.2807/1560-7917.ES.2024.29.4.2400033 · doi:10.2807/1560-7917.es.2024.29.4.2400033
  22. Paulson S, Munro APS, Cathie K, Bedford H, Jones CE. Protecting against respiratory syncytial virus: an online questionnaire study exploring UK parents' acceptability of vaccination in pregnancy or monoclonal antibody administration for infants. Pediatr Infect Dis J 2025; 44(2S): S158–S61. · DOI
  23. Harteveld, 2025, Respiratory syncytial virus (RSV) prevention: perception and willingness of expectant parents in the Netherlands, Vaccine, 44, 10.1016/j.vaccine.2024.126541 · DOI
  24. Adhikari, 2024, Acceptance of new respiratory syncytial virus vaccine among pregnant women in Nepal for future routine immunization: a descriptive crosssectional study, JNMA J Nepal Med Assoc, 62, 372, 10.31729/jnma.8622 · DOI · Paper page
  25. Greenacre, 2016, The importance of selection Bias in internet surveys, Open J Stat, 06, 397, 10.4236/ojs.2016.63035 · DOI · Paper page
  26. Jabagi MJ, Bertrand M, Gabet A, Kolla E, Olie V, Zureik M. Nirsevimab vs RSVpreF vaccine for respiratory syncytial virus-related hospitalization in newborns. JAMA 2025. · DOI
  27. Sacre, 2023, Socioeconomic inequalities in vaccine uptake: a global umbrella review, PloS One, 18, 10.1371/journal.pone.0294688 · DOI
  28. Truong, 2022, What factors promote vaccine hesitancy or acceptance during pandemics? A systematic review and thematic analysis, Health Promot Int, 37, 10.1093/heapro/daab105 · DOI · Paper page
  29. Wang, 2025, Pregnant women’s choices for preventing respiratory syncytial virus (RSV), Vaccine, 48, 10.1016/j.vaccine.2025.126790 · DOI
  30. Tucker T, Garvey Z, O'Sullivan D, Loza A. Acceptance of the respiratory syncytial virus vaccine in pregnant individuals. O G Open; 2024: 26. · DOI · Paper page
  31. Hinderstein S, Aragona E, Loyal J. Parent perspectives on Nirsevimab for their newborn. Pediatrics 2024; 154(6). · DOI
  32. Madhi, 2025, Preterm birth frequency and associated outcomes from the MATISSE (maternal immunization study for safety and efficacy) maternal trial of the bivalent respiratory syncytial virus prefusion F protein vaccine, Obstet Gynecol, 145, 147, 10.1097/AOG.0000000000005817 · doi:10.1097/aog.0000000000005817
  33. Saif-Ur-Rahman KM, King C, Whelan SO, et al. Efficacy and safety of respiratory syncytial virus vaccines. Cochrane Database Syst Rev 2025; 9(9): CD016131. · DOI
  34. Rehman, 2022, COVID-19 vaccine reluctance and possible driving factors: a comparative assessment among pregnant and non-pregnant women, Front Public Health, 10, 1100130, 10.3389/fpubh.2022.1100130 · DOI

Metadata

Authors
Favre, G., Pfund, A., Gerbier, E., Anselem, O., Balaya, V., Ceccaldi, P.-F., Chalouhi, G., Ducarme, G., Garabedian, C., Guerby, P., Mottet, N., Picone, O., Poncelet, C., Quibel, T., Sananes, N., Sentilhes, L., Simon, J., Tran, P. L., Ville, Y., Baud, D., Blume, C., Capoccia Brugger, R., Farin, A., Fougère, Y., Fruscalzo, A., Gallmann, D., Haslinger, C., Huber, D., Martinez de Tejada, B., Radan, A.-P., Schäffer, L., Todesco Bernasconi, M., Vökt, C., Miranda, J., Nieto-Calvache, A. J., Rivera-Torres, L. F., De Santis, M., Kratochwila, C., Paladini, D., Tantari, M., Ernst, C., Mossong, J., Murray, J., Feuerschuette, O. H. M., Luz, A. G., Surita, F., Boucoiran, I., Goncé, A., Higgins, M., Démolis, R., Alexandre, K., & Pomar, L.
Venue
Vaccine
Publisher
Elsevier BV
Published
2026-08
Volume
88
Pages
128783
ISSN
0264-410X
DOI
10.1016/j.vaccine.2026.128783
Cited by
2
Language
en
Licence
Funders
University of Applied Sciences and Arts Western Switzerland

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Acceptability and preferences regarding RSV immunisation during pregnancy: a cross-sectional study in diverse global settings. https://app.cochat.ai/papers/10.1016/j.vaccine.2026.128783
The paper
Favre, G., Pfund, A., Gerbier, E., Anselem, O., Balaya, V., Ceccaldi, P.-F., Chalouhi, G., Ducarme, G., Garabedian, C., Guerby, P., Mottet, N., Picone, O., Poncelet, C., Quibel, T., Sananes, N., Sentilhes, L., Simon, J., Tran, P. L., Ville, Y., . . . Pomar, L. (2026). Acceptability and preferences regarding RSV immunisation during pregnancy: a cross-sectional study in diverse global settings. Vaccine. https://doi.org/10.1016/j.vaccine.2026.128783

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.